Related scientific articles (all)

Liquid-Based Cytology of the Breast: Pitfalls Unrecognized before Specific Liquid-Based Cytology Training - Proposal for a Modification of the Diagnostic Criteria.

Authors : Feoli F, Ameye L, Van Eeckhout P, Paesmans M, Marra V, Arisio R
Year : 2013
Journal : Acta Cytol.
Volume : 57(4)
Pages : 369-76

The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.

Authors : Klastersky J, Paesmans M
Year : 2013
Journal : Support Care Cancer
Volume : 21(5)
Pages : 1487-95

Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.

Authors : Wibmer T, Berghmans T, Kropf-Sanchen C, Lafitte JJ, Rüdiger S, Paesmans M, Blanta I, Scherpereel A, Stoiber KM, Rottbauer W, Sculier JP, Schumann C
Year : 2013
Journal : Lung
Volume : 191(3)
Pages : 271-80

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Authors : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Borbath I, Dresse D, Houbier G, Fried M, Awada A, Piccart-Gebhart M, Laethem JL, Flamen P
Year : 2013
Journal : BMC Cancer
Volume : 13(1)
Pages : 190

Single-access laparoscopic primary and incisional prosthetic hernia repair: first 50 patients.

Authors : Dapri G, Bruyns J, Paesmans M, Himpens J, Cadière GB
Year : 2013
Journal : Hernia
Volume : 17(5)
Pages : 619-26

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Authors : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Year : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pages : 14-21

Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.

Authors : Antoine C, Ameye L, Paesmans M, Rozenberg S
Year : 2012
Journal : Maturitas
Volume : 72(4)
Pages : 317-23

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.

Authors : Rossari JR, Metzger-Filho O, Paesmans M, Saini KS, Gennari A, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : J Oncol
Volume : 2012
Pages : 417673

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Authors : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Year : 2012
Journal : Lung Cancer
Volume : 77(3)
Pages : 605-610

M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy.

Authors : Ameye L, Paesmans M, Thiel S, Jensenius JC, Aoun M
Year : 2012
Journal : Clin. Exp. Immunol.
Volume : 167(2)
Pages : 303-8

Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplasic syndrome: a bicentric study.

Authors : Vaes M, Hites M, Cotton F, Bourguignon AM, Csergo M, Rasson C, Ameye L, Bron D, Jacobs F, Aoun M
Year : 2012
Journal : Antimicrob. Agents Chemother.
Volume : 56(12))
Pages : 6298-303

The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer.

Authors : Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A, Gidron Y
Year : 2012
Journal : Auton Neurosci
Volume : 166(1-2)
Pages : 96-9

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Authors : Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(4)
Pages : 853-859

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Authors : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Year : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pages : 9-28

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

Authors : Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart-Gebhart M, Flamen P
Year : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1687-93

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Authors : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Year : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

Surgical management of toxic multinodular goiter.

Authors : Digonnet A, Willemse E, Dekeyser C, de Saint-Aubain de Somerhausen N, Moreau M, Andry G
Year : 2011
Journal : World Journal of Endocrine Surgery
Volume : 3(2)
Pages : 69-73

Tomographie par émission de positons au 18F-FDG et réponse anticancéreuse. Détermination de la réponse à la chimiothérapie de première ligne des cancers bronchiques non à petites cellules avancés : critères métaboliques ou morphologiques ?

Authors : van Ruychevelt V, Garcia C, Meert AP, Berghmans T, Paesmans M, Flamen P, Sculier JP
Year : 2011
Journal : Rev Mal Respir
Volume : 28(5)
Pages : 618-25

Treatment of febrile neutropenia is expensive: prevention is the answer.

Authors : Klastersky J, Paesmans M
Year : 2011
Journal : Onkologie
Volume : 34(5)
Pages : 226-8

Neoadjuvant anthracycline and trastuzumab for breast cancer: is concurrent treatment safe?

Authors : Bozovic-Spasojevic I, Azim HA, Paesmans M, Suter T, Piccart-Gebhart M, de Azambuja E
Year : 2011
Journal : Lancet Oncol
Volume : 12(3)
Pages : 209-11